Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  recombinant interferon beta
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 49 for your search:
Start Over
Phase II/III Study of IFN-beta-ser/IFN-gamma Followed by DDP/VP-16 in Patients with Inoperable non-Small Cell Lung Cancer (Summary Last Modified 04/88)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: WCCC-CO-8751, NCI-V87-0225
Phase III Randomized Study of Conventional Radiotherapy with vs without IFN-B in Patients with Locally Advanced non-Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9304, RTOG-93-04
Pilot Phase I-II Evaluation of Human Fibroblast Interferon for Disseminated Breast Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-7866
Phase I/II Study of Radiotherapy with IFN-B Radiosensitization for Malignant Glioma (Summary Last Modified 07/96)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: URCC-4393MR, NCI-V94-0600
Phase I-II Immunotherapy with Human Leukocyte & Fibroblast Interferon for Breast, Bronchogenic, and Colon Carcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 16 to 75
Sponsor:
Protocol IDs: WCCC-CO-8091
Phase I/II Immunotherapy with Intravesicular Beta-Interferon in Patients with Recurrent Superficial Bladder Carcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NBCG-17
Phase I/II Study of Intraventricular IFN-beta-ser in Patients with Carcinomatous Meningitis (Summary Last Modified 03/88)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: UAB-387, NCI-V87-0160
Phase II Study of Recombinant Human Interferon Beta-1a (Avonex) in Patients with Recurrent Gliomas or Astrocytomas (Summary Last Modified 12/2001)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-NCNSC-96314, NCI-T94-0125, T94-0125
Phase II Study of Radiotherapy Followed by Recombinant Interferon Beta in Patients with Supratentorial Glioblastoma Multiforme
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9710, RTOG-97-10
Phase II Immunotherapy with IFN-beta-ser for Favorable Prognosis Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: AECM-8508188, NCI-V86-0030
Phase II Immunotherapy with Human Fibroblast Interferon for Metastatic or Recurrent Soft Tissue Sarcomas
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: ICC-81M1, NCI-V83-0226
Phase II Interferon-B Immunotherapy for Recurrent Glioblastoma Multiforme
Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 to 75
Sponsor:
Protocol IDs: YALE-HIC-2830, NCI-V83-0022
Phase II Immunotherapy with Beta (Fibroblast) Interferon for Recurrent Disseminated Breast Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: FHCRC-151, NCI-V83-0105
Phase II Immunotherapy with IFN-b-ser in Patients with Recurrent and/or Metastatic Carcinoma of the Head and Neck
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: OSP-8503, NCI-V85-0084
Phase II Immunotherapy with Intravenous IFN-b-ser in Patients with Renal Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: UMCC-8501, NCI-V85-0080
Phase II Immunotherapy with Recombinant Beta Interferon in Patients with Measurable Hairy Cell Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: AECM-TB01-23485, NCI-V85-0225
Phase II Immunotherapy with IFN-beta-ser in Patients with Measurable Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: OSP-8504, NCI-V85-0255
Phase II Immunotherapy with Recombinant Beta Interferon in Patients with Diffuse Malignant Mesothelioma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8526
Phase II Immunotherapy with Intravenous IFN-beta-ser in Patients with Kaposi's Sarcoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CHSF-85039, NCI-V86-0123
Phase II Randomized Study of Immunotherapy with IL-2 vs IL-2/b-IFN in Patients with Refractory or Relapsed non-Hodgkin's Lymphoma (Summary Last Modified 06/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8653, CALGB-8653
Phase II Master Protocol for the Evaluation of New Treatments in Patients with Advanced Soft Tissue Sarcomas --- MEN vs IFN-beta-ser
Phase: Phase II
Type: Treatment
Status: Completed
Age: 14 and over
Sponsor: NCI
Protocol IDs: EST-1785
Phase II Immunotherapy with Subcutaneous IFN-beta-ser in Patients with Chronic Myelogenous Leukemia (Summary Last Modified 11/87)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor:
Protocol IDs: UCLA-8611546, NCI-V87-0184
Start Over